is metformin a glp 1 medication vs. GLP-1 Receptor Agonists: Which Diabetes Right for You? Comparing Glucagon‐like peptide‐1 receptor agonists

Difficulty concentrating

Initial disinterest in the use of GIP has abated and the most prominent, recent approaches to dual incretins are unimolecular combinations of GIP with GLP-1R agonism

To overcome this limitation, the pharmaceutical industry developed GLP-1 analogs, compounds designed to mimic the hormones action while extending its duration

In the obesity trial, serious adverse events (SAEs) occurred in 4% of participants with retatrutide use overall (06% across groups) vs

However, a number of pitfalls in the methodology of these studies (e.g

Working with the medication means choosing carbohydrates that support those effects rather than fighting them